These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16531985)

  • 41. Urantide attenuates myocardial damage in atherosclerotic rats by regulating the MAPK signalling pathway.
    Zhao J; Miao G; Wang T; Li J; Xie L
    Life Sci; 2020 Dec; 262():118551. PubMed ID: 33038370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
    Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
    J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.
    Bousette N; Hu F; Ohlstein EH; Dhanak D; Douglas SA; Giaid A
    J Mol Cell Cardiol; 2006 Aug; 41(2):285-95. PubMed ID: 16797584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension.
    Liu D; Chen J; Wang J; Zhang Z; Ma X; Jia J; Wang Y
    Int J Mol Med; 2010 Jun; 25(6):845-51. PubMed ID: 20428787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits.
    Yu QQ; Cheng DX; Xu LR; Li YK; Zheng XY; Liu Y; Li YF; Liu HL; Bai L; Wang R; Fan JL; Liu EQ; Zhao SH
    Acta Pharmacol Sin; 2020 Apr; 41(4):546-553. PubMed ID: 31685976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urotensin II evokes neurotransmitter release from rat cerebrocortical slices.
    Ono T; Kawaguchi Y; Kudo M; Kushikata T; Hashiba E; Yoshida H; Kudo T; Furukawa K; Douglas SA; Guerrini R; Calo' G; Hirota K
    Neurosci Lett; 2008 Aug; 440(3):275-9. PubMed ID: 18572318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat.
    Zhang Y; Li Y; Wei R; Wang Z; Bu D; Zhao J; Pang Y; Tang C
    Regul Pept; 2008 Nov; 151(1-3):88-94. PubMed ID: 18955090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function.
    Vaudry H; Leprince J; Chatenet D; Fournier A; Lambert DG; Le Mével JC; Ohlstein EH; Schwertani A; Tostivint H; Vaudry D
    Pharmacol Rev; 2015; 67(1):214-58. PubMed ID: 25535277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease.
    Bousette N; Pottinger J; Ramli W; Ohlstein EH; Dhanak D; Douglas SA; Giaid A
    Peptides; 2006 Nov; 27(11):2919-26. PubMed ID: 16919371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
    Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV
    Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.
    Chatenet D; Létourneau M; Nguyen QT; Doan ND; Dupuis J; Fournier A
    Br J Pharmacol; 2013 Feb; 168(4):807-21. PubMed ID: 22994258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.
    Camarda V; Song W; Marzola E; Spagnol M; Guerrini R; Salvadori S; Regoli D; Thompson JP; Rowbotham DJ; Behm DJ; Douglas SA; Calo' G; Lambert DG
    Eur J Pharmacol; 2004 Sep; 498(1-3):83-6. PubMed ID: 15363979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urotensin II, from fish to human.
    Vaudry H; Do Rego JC; Le Mevel JC; Chatenet D; Tostivint H; Fournier A; Tonon MC; Pelletier G; Conlon JM; Leprince J
    Ann N Y Acad Sci; 2010 Jul; 1200():53-66. PubMed ID: 20633133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potent cardiovascular effects of homologous urotensin II (UII)-related peptide and UII in unanesthetized eels after peripheral and central injections.
    Nobata S; Donald JA; Balment RJ; Takei Y
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R437-46. PubMed ID: 21123764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes.
    Castel H; Diallo M; Chatenet D; Leprince J; Desrues L; Schouft MT; Fontaine M; Dubessy C; Lihrmann I; Scalbert E; Malagon M; Vaudry H; Tonon MC; Gandolfo P
    J Neurochem; 2006 Oct; 99(2):582-95. PubMed ID: 16942596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway.
    Xu S; Jiang H; Wu B; Yang J; Chen S
    Tohoku J Exp Med; 2009 Dec; 219(4):283-8. PubMed ID: 19966526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of urotensin II on functional activity of late endothelial progenitor cells.
    Yi K; Yu M; Wu L; Tan X
    Peptides; 2012 Jan; 33(1):87-91. PubMed ID: 22123628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urotensin II upregulates migration and cytokine gene expression in leukocytes of the African clawed frog, Xenopus laevis.
    Tomiyama S; Nakamachi T; Uchiyama M; Matsuda K; Konno N
    Gen Comp Endocrinol; 2015 May; 216():54-63. PubMed ID: 25907658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arrestin-independent internalization and recycling of the urotensin receptor contribute to long-lasting urotensin II-mediated vasoconstriction.
    Giebing G; Tölle M; Jürgensen J; Eichhorst J; Furkert J; Beyermann M; Neuschäfer-Rube F; Rosenthal W; Zidek W; van der Giet M; Oksche A
    Circ Res; 2005 Sep; 97(7):707-15. PubMed ID: 16141412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.